As New England’s largest essential hospital, the 654-bed flagship academic medical center blends clinical excellence with a deep commitment to access and equity. As the primary teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center is a national leader in research, ranking second among essential hospitals for National Institutes of Health funding and producing over 1,600 research publications in fiscal year 2025. It is nationally ranked in geriatrics, neurology and neurosurgery, urology, and gastroenterology & GI surgery by U.S. News & World Report for 2026–27, and named “Best Regional Hospital” and “Best Regional Hospital for Community Access.” Two specialties and 11 procedures and conditions were recognized as “high-performing.” The medical center is home to New England’s largest sickle cell disease center and in 2023 became the region’s first hospital to offer breakthrough gene therapies for sickle cell disease. It delivers culturally responsive care through the region’s most extensive interpreter services program, providing translation in over 150 languages for a highly diverse patient population. The hospital also redefines innovation through first-in-the-nation programs addressing social and environmental drivers of health, including “Clean Power Prescription” and rooftop urban farming initiatives. In 2026, 187 Boston Medical Center physicians were named “Top Doctors” by Castle Connolly and Boston Magazine. Practice Greenhealth recognized it with a “Circles of Excellence Award” and the medical center earned recognition from Castle Connolly, Forbes, Newsweek and The Joint Commission for excellence in clinical care, workforce culture and sustainability.
